SOLIGENIX, INC. — Director's Dealing 2019

Dec 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2019-12-12

Reporting Person: Straube Richard (SVP and CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-12	Option (Right to Buy)	$1.24	A	30000	Acquired	2029-12-11	Common Stock (30000)	Direct

Footnotes

F1: The stock option vested immediately as to 7,500 shares and vests as to the remainder at a rate of 1,875 of the shares on each three (3) month anniversary of December 12, 2019.